Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.90 USD | +2.19% |
|
-4.26% | -24.05% |
01/07 | MGP Ingredients, Inc.(NasdaqGS:MGPI) added to Russell 3000 Value Index | CI |
01/07 | MGP Ingredients, Inc.(NasdaqGS:MGPI) added to Russell 2000 Value-Defensive Index | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.31 | 8.67 | 8.47 | 8.68 | 7.35 | |||||
Return on Total Capital | 13.3 | 10.22 | 9.91 | 10.34 | 8.85 | |||||
Return On Equity % | 16.35 | 20.03 | 15.67 | 13.44 | 4.1 | |||||
Return on Common Equity | 16.24 | 19.97 | 15.61 | 13.32 | 4.07 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 26.55 | 28.35 | 32.38 | 36.43 | 40.69 | |||||
SG&A Margin | 10.78 | 12.76 | 13.34 | 15.25 | 17.31 | |||||
EBITDA Margin % | 19.04 | 18.63 | 21.78 | 23.82 | 26.51 | |||||
EBITA Margin % | 15.77 | 15.83 | 19.31 | 21.51 | 23.85 | |||||
EBIT Margin % | 15.77 | 15.59 | 19.04 | 21.18 | 23.38 | |||||
Income From Continuing Operations Margin % | 10.2 | 14.49 | 13.92 | 12.81 | 4.9 | |||||
Net Income Margin % | 10.2 | 14.57 | 13.99 | 12.85 | 4.93 | |||||
Net Avail. For Common Margin % | 10.13 | 14.46 | 13.88 | 12.72 | 4.87 | |||||
Normalized Net Income Margin | 9.6 | 9.29 | 11.27 | 12.76 | 14.11 | |||||
Levered Free Cash Flow Margin | 6.94 | -12.13 | 3.05 | 0.34 | 0.7 | |||||
Unlevered Free Cash Flow Margin | 7.2 | -11.73 | 3.48 | 0.84 | 1.45 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.15 | 0.89 | 0.71 | 0.66 | 0.5 | |||||
Fixed Assets Turnover | 2.91 | 3.54 | 3.35 | 3.17 | 2.31 | |||||
Receivables Turnover (Average Receivables) | 8.08 | 8.38 | 7.75 | 6.6 | 4.81 | |||||
Inventory Turnover (Average Inventory) | 2.09 | 2.32 | 1.98 | 1.67 | 1.17 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.17 | 4.13 | 4.31 | 4.51 | 5.91 | |||||
Quick Ratio | 1.47 | 1.35 | 1.53 | 1.44 | 1.92 | |||||
Operating Cash Flow to Current Liabilities | 1 | 0.99 | 0.84 | 0.73 | 1.11 | |||||
Days Sales Outstanding (Average Receivables) | 45.3 | 43.54 | 47.07 | 55.32 | 76.14 | |||||
Days Outstanding Inventory (Average Inventory) | 175.07 | 157.27 | 184.78 | 218.45 | 312.14 | |||||
Average Days Payable Outstanding | 37.14 | 27.67 | 38.28 | 43.39 | 58.81 | |||||
Cash Conversion Cycle (Average Days) | 183.23 | 173.13 | 193.58 | 230.38 | 329.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 17.16 | 37.76 | 32.96 | 35.55 | 40.8 | |||||
Total Debt / Total Capital | 14.64 | 27.41 | 24.79 | 26.23 | 28.97 | |||||
LT Debt/Equity | 15.74 | 36.81 | 31.7 | 34.41 | 39.53 | |||||
Long-Term Debt / Total Capital | 13.44 | 26.72 | 23.84 | 25.38 | 28.07 | |||||
Total Liabilities / Total Assets | 28.38 | 38.14 | 35.62 | 39.02 | 40.78 | |||||
EBIT / Interest Expense | 38.03 | 24.2 | 27.33 | 26.65 | 19.5 | |||||
EBITDA / Interest Expense | 47.69 | 29.77 | 32.12 | 30.7 | 22.58 | |||||
(EBITDA - Capex) / Interest Expense | 35.68 | 18.03 | 23.81 | 22.39 | 14.14 | |||||
Total Debt / EBITDA | 0.58 | 2.02 | 1.4 | 1.48 | 1.78 | |||||
Net Debt / EBITDA | 0.3 | 1.84 | 1.13 | 1.39 | 1.65 | |||||
Total Debt / (EBITDA - Capex) | 0.77 | 3.34 | 1.89 | 2.03 | 2.85 | |||||
Net Debt / (EBITDA - Capex) | 0.4 | 3.05 | 1.52 | 1.9 | 2.63 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.04 | 58.45 | 24.83 | 6.92 | -15.89 | |||||
Gross Profit, 1 Yr. Growth % | 37.19 | 86.89 | 42.38 | 20.29 | -6.04 | |||||
EBITDA, 1 Yr. Growth % | 28.07 | 83.98 | 45.65 | 16.93 | -6.4 | |||||
EBITA, 1 Yr. Growth % | 32.01 | 96.47 | 51.85 | 19.13 | -6.75 | |||||
EBIT, 1 Yr. Growth % | 32.01 | 93.39 | 52.14 | 18.93 | -7.13 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4 | 125.1 | 19.88 | -1.6 | -67.83 | |||||
Net Income, 1 Yr. Growth % | 4 | 126.32 | 19.88 | -1.82 | -67.75 | |||||
Normalized Net Income, 1 Yr. Growth % | 32.19 | 90.71 | 51.04 | 21.07 | -7.01 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 4.47 | 83.38 | 12.59 | -2.44 | -67.55 | |||||
Accounts Receivable, 1 Yr. Growth % | 39.18 | 62.44 | 18.08 | 32.05 | 2.91 | |||||
Inventory, 1 Yr. Growth % | 2.98 | 74.41 | 17.8 | 19.72 | 5.22 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.66 | 58.2 | 15.54 | 10.21 | 20.25 | |||||
Total Assets, 1 Yr. Growth % | 13.63 | 184.11 | 11.21 | 20.22 | 0.96 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.96 | -22.9 | 52.12 | -15.29 | 23.59 | |||||
Common Equity, 1 Yr. Growth % | 13.63 | 145.6 | 15.82 | 13.9 | -1.92 | |||||
Cash From Operations, 1 Yr. Growth % | 170.03 | 65.74 | 0.76 | -5.79 | 22.07 | |||||
Capital Expenditures, 1 Yr. Growth % | 17.76 | 140.54 | -4.36 | 21.94 | 28.79 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -663.86 | -486.81 | -131.42 | -88.1 | 73.86 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -802.59 | -448.83 | -137.15 | -74.34 | 46 | |||||
Dividend Per Share, 1 Yr. Growth % | 20 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.55 | 31.44 | 40.64 | 15.53 | -5.17 | |||||
Gross Profit, 2 Yr. CAGR % | 12.07 | 52.37 | 63.27 | 30.87 | 6.32 | |||||
EBITDA, 2 Yr. CAGR % | 10.66 | 40.91 | 63.92 | 30.51 | 4.62 | |||||
EBITA, 2 Yr. CAGR % | 11.52 | 44.93 | 73.01 | 35.56 | 6.13 | |||||
EBIT, 2 Yr. CAGR % | 11.52 | 43.79 | 71.82 | 34.52 | 5.1 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 4.02 | 53.01 | 64.27 | 8.61 | -43.74 | |||||
Net Income, 2 Yr. CAGR % | 4.02 | 53.42 | 64.72 | 8.49 | -43.73 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.34 | 42.44 | 70.01 | 35.23 | 6.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 4.47 | 38.41 | 44.18 | 4.8 | -43.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | 21.17 | 50.36 | 38.5 | 24.87 | 16.57 | |||||
Inventory, 2 Yr. CAGR % | 13.86 | 34.02 | 43.34 | 18.76 | 12.23 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.56 | 26.81 | 35.2 | 12.85 | 15.12 | |||||
Total Assets, 2 Yr. CAGR % | 14.85 | 79.68 | 77.75 | 15.62 | 10.17 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.37 | -6.67 | 8.3 | 13.52 | 2.32 | |||||
Common Equity, 2 Yr. CAGR % | 14.16 | 67.05 | 68.65 | 14.85 | 5.69 | |||||
Cash From Operations, 2 Yr. CAGR % | 26.12 | 111.55 | 29.23 | -2.57 | 7.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | -20.34 | 68.3 | 51.68 | 7.99 | 25.32 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 84.76 | 295.15 | 10.23 | -80.66 | -54.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 97.34 | 325.84 | 13.8 | -69.13 | -38.8 | |||||
Dividend Per Share, 2 Yr. CAGR % | 22.47 | 9.54 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.41 | 18.56 | 29.2 | 28.36 | 3.93 | |||||
Gross Profit, 3 Yr. CAGR % | 11.37 | 28.57 | 49.03 | 47.46 | 17.19 | |||||
EBITDA, 3 Yr. CAGR % | 11.58 | 23.82 | 42.57 | 46.47 | 16.82 | |||||
EBITA, 3 Yr. CAGR % | 13.27 | 25.55 | 47.32 | 52.77 | 19.67 | |||||
EBIT, 3 Yr. CAGR % | 13.27 | 24.89 | 46.64 | 51.99 | 18.89 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -1.19 | 34.55 | 41.05 | 38.48 | -27.6 | |||||
Net Income, 3 Yr. CAGR % | -1.19 | 34.79 | 41.31 | 38.62 | -27.59 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.64 | 23.92 | 45.37 | 51.82 | 19.36 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -0.98 | 26.02 | 29.5 | 26.58 | -29.1 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.37 | 33.61 | 38.72 | 36.31 | 17.07 | |||||
Inventory, 3 Yr. CAGR % | 14.82 | 31.25 | 28.38 | 34.99 | 14.06 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10 | 21.56 | 22.94 | 26.3 | 15.26 | |||||
Total Assets, 3 Yr. CAGR % | 15.11 | 55.33 | 53.12 | 56.03 | 10.52 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.34 | -0.3 | 9.83 | -0.21 | 16.78 | |||||
Common Equity, 3 Yr. CAGR % | 15.88 | 47.37 | 47.85 | 47.97 | 8.96 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.74 | 38.14 | 65.21 | 16.3 | 5.04 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.19 | 15.14 | 39.4 | 41.03 | 14.52 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 74.68 | 111.44 | 69.82 | -47.51 | -59.79 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 69.09 | 115.81 | 88.74 | -30.74 | -48.18 | |||||
Dividend Per Share, 3 Yr. CAGR % | 44.22 | 14.47 | 6.27 | 0 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.84 | 14.51 | 17.63 | 17.34 | 14.17 | |||||
Gross Profit, 5 Yr. CAGR % | 12.4 | 22.17 | 27.22 | 29.52 | 30.2 | |||||
EBITDA, 5 Yr. CAGR % | 10.74 | 18.56 | 25.74 | 26.5 | 25.97 | |||||
EBITA, 5 Yr. CAGR % | 13.68 | 20.79 | 28.62 | 29.11 | 28.85 | |||||
EBIT, 5 Yr. CAGR % | 13.68 | 20.41 | 28.26 | 28.71 | 28.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.03 | 23.84 | 21.09 | 23.5 | -2.34 | |||||
Net Income, 5 Yr. CAGR % | 9.03 | 23.97 | 21.22 | 23.58 | -2.23 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.59 | 17.66 | 27.81 | 28.39 | 28.17 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.86 | 19.03 | 15.08 | 17.22 | -7.22 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.18 | 28.82 | 26.04 | 30.04 | 29.4 | |||||
Inventory, 5 Yr. CAGR % | 19.16 | 25.54 | 25.48 | 26.1 | 21.66 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.42 | 18.52 | 19.46 | 18 | 19.75 | |||||
Total Assets, 5 Yr. CAGR % | 13.54 | 35.82 | 36.96 | 38.03 | 34.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 17.39 | 6.69 | 12.47 | 5.01 | 6.76 | |||||
Common Equity, 5 Yr. CAGR % | 17.71 | 34.54 | 34.65 | 33.38 | 29.27 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.33 | 34.95 | 21.59 | 20.14 | 38.98 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.39 | 21.47 | 16.57 | 12.23 | 33.59 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 45.71 | 118.23 | 35.86 | -18.81 | 0.27 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 49.24 | 151.73 | 35.85 | -0.89 | 20.29 | |||||
Dividend Per Share, 5 Yr. CAGR % | 51.57 | 31.95 | 24.57 | 8.45 | 3.71 |
- Stock Market
- Equities
- MGPI Stock
- Financials MGP Ingredients, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition